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Abstract
Background Pelvic bleeding from trauma and postpartum
hemorrhage is often difficult to treat successfully by
emergency providers particularly in low resource environ-
ments, when hospital presentation is delayed or there is a
lack of immediate surgical, anesthesia, and transfusion
capabilities. Pneumatic anti-shock garments (PASG) de-
crease pelvic blood flow and hemorrhage. A tightly fitted
neoprene non-pneumatic anti-shock garment (NASG) has
been shown to decrease blood loss and improve survival
rates from postpartum hemorrhage.
Aims The objective of this study was to determine whether
blood flow to the pelvis is decreased by use of the NASG
or by an improvised PASG.
Methods A PASG was made using three bicycle tubes,
placing one tube on each leg and one on the lower abdomen/
pelvis, wrapping firmly with sheets and inflating the tubes to
approximately 3.5 bar (45 psi). A Doppler ultrasound was
usedtomeasuredistalaorticbloodflowin12healthyadultsat
baseline and in both devices. Data were analyzed with one
sample and paired t tests.
Results Mean flow was 1.99 l/min at baseline. Mean flow
decrease was 1.11 [95% confidence interval (CI): 0.64–
1.57, p=0.0003 for the difference] for the PASG and 0.65
(95% CI: 0.03–1.26, p=0.04) for the NASG. The PASG
decreased blood flow more than the NASG (mean
difference: 0.46, 95% CI: 0.02–0.90, p=0.04).
Conclusions Both devices decreased distal aortic blood
flow, but the improvised PASG device decreased it by a
larger margin.
Keywords Pelvic trauma.Emergency obstetric care.
Postpartum hemorrhage.Anti-shock trousers
Introduction
Hemorrhage from pelvic blood vessels after trauma or
obstetric delivery are major health care problems. Trauma is
a leading cause of death worldwide and a major cause of
lost quality-adjusted life years (QALYs) [1]. Treatment of
pelvic trauma is difficult since hemorrhage can be massive
and it is difficult to apply direct pressure to the bleeding
vessels. Postpartum hemorrhage is the leading cause of
obstetric deaths and causes an estimated 150,000 maternal
deaths per year [1]. Definitive control of severe pelvic
bleeding from any cause often requires aggressive measures
such as arterial embolization, laparotomy, internal fixation,
or pelvic packing. These procedures are difficult to perform
because they require immediate access to sophisticated
medical and surgical expertise and equipment. Severe
hemorrhage is often aggravated by disseminated intravas-
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transfusion of red blood cells, platelets, and clotting factors.
Transfusion requirements can be massive and overwhelm
the capacity of even large facilities. These issues are
particularly difficult in low resource environments.
Ideally pelvic hemorrhage could be controlled by simple
external pressure. This could provide time to mobilize more
sophisticated resources and might decrease transfusion
requirements and the need for aggressive therapy. Pneu-
matic anti-shock garments (PASG), also called medical or
military anti-shock trousers (MAST), have been shown to
greatly decrease pelvic blood flow [2, 3], and case reports
imply that they are effective in patients with pelvic injuries
[4] and postpartum hemorrhage [5]. PASG have little or no
benefit in treating trauma patients in general [6]. However,
most of the patients enrolled in clinical trials had thoracic or
abdominal trauma and had ready access to definitive
surgery. In addition PASG have little effect on the general
circulation. They only autotransfuse about 250 cc of blood
[7] from the lower body into the central circulation and
have little or no effect on cardiac output [2]. These findings
would explain differing outcomes for upper body versus
pelvic hemorrhage. In their favor PASG have been used
thousands of times and have proven quite safe. Unfortu-
nately PASG are complicated, expensive, and rarely
available in the low resource areas where they would seem
most useful. A simple and less expensive alternative to
PASG was developed by The National Aeronautics and
Space Administration (NASA). This non-pneumatic anti-
shock garment (NASG) is made of neoprene and is tightly
applied to the patient using Velcro™ straps. It has been
commercialized as the ZOEX Non-Inflatable Anti-Shock
Garment™ (ZOEX, Ashland, OR, USA). The NASG has
been shown to decrease postpartum blood loss by 50% [8,
9] and improve survival rates from postpartum hemorrhage
[10]. Although the NASG is less expensive than commer-
cial PASGs it currently has limited availability.
We designed a PASG that can be made from inexpensive
and easily available supplies. We measured pelvic blood
flow in volunteers before and after being placed in the
NASG and PASG. Our null hypothesis was that neither
device would affect blood flow to the pelvis.
Materials and methods
Review and approval of the study protocol was obtained
from our Institutional Review Board. Twelve healthy
nonpregnant adult volunteers were selected. Subjects
ranged in age from 21 to 60 years of age and weighed
52–82 kg. The sample size was based on previous research
[3]. Written informed consent was obtained from each
subject. A physician was present during each trial.
An Acuson Sequoia 512 Ultrasound and 4VI probe
operating at 2–3 MHz (Siemens, Mountain View, CA,
USA) was used to measure heart rate, apparent artery
diameter, Doppler-to-vessel angle, and blood flow velocity
at the abdominal aorta below the superior mesenteric artery
(SMA). These were used to calculate flow rate (volume per
time). Details of this technique have been published
elsewhere [3]. Measurements were obtained from each
subject at baseline and immediately after being placed in
each device. Device order was alternated between subjects
with the initial subject’s order mechanically randomized.
The PASG was made by wrapping individual folded
hospital sheets around each leg and the abdomen/pelvis.
After the first wrap a bicycle tube was placed on each sheet
and the sheet was further wrapped around the patient and
tube. A second set of three sheets was then wrapped firmly
around the first set being careful to allow the tube stem but
no other part to protrude. The tubes were then inflated with
a bicycle pump to 2.8–3.5 bar (40–50 psi). The ultraso-
nographer has 20 years experience and is certified by the
American Registry for Diagnostic Medical Sonography
(Rockville, MD, USA) as both a registered diagnostic
medical sonographer (RDMS) and a registered vascular
technician (RVT). Data were analyzed with one sample and
paired t tests using two-tailed p values.
Results
Mean blood flow was 1.99 l/min at baseline with a range of
0.39–3.05 l/min. Mean flow decrease was 1.11 l/min or
56% [95% confidence interval (CI): 0.64–1.57, p=0.0003
for the difference] for the PASG and 0.65 l/min or 33%
(95% CI: 0.03–1.26, p=0.04) for the NASG. The PASG
decreased blood flow more than the NASG (mean
difference: 0.46, 95% CI: 0.02–0.90, p=0.04).
Discussion
Our results are compatible with the medical literature
regarding the regional hemodynamic effects of circumfer-
ential abdominal pelvic pressure using PASG [2, 3].
Commercial PASG are quite rigid and their air bladders
are considerably larger than bicycle tubes. A previous study
showed that when inflated to two thirds of their maximum,
commercial PASG decrease blood flow by approximately
one half, which is similar to the magnitude of decrease we
demonstrated with our improvised PASG. Fully inflated
commercial PASG decrease distal aortic flow by about
three quarters [2, 3].
Pelvic hemorrhage and particularly postpartum hem-
orrhage is multifactorial. Bleeding can be arterial from
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sacral arteries. Bleeding can also be from veins,
capillaries, and uterine spiral arterioles. Bleeding will
stop when externally applied pressure exceeds the
perfusion pressure of the injured vessel. Low pressure
venous bleeding theoretically requires only a few milli-
bars, but this must be at the actual bleeding sites. This
can be difficult to apply when the affected vessels are
pelvic or retroperitoneal. Complete elimination of arterial
bleeding requires pressure that exceeds the systemic
blood pressure. This is impossible to apply externally
and would in addition completely eliminate tissue
perfusion, causing undesirable side effects.
Circumferential pressure can be viewed as having two
independent effects on hemorrhage. It provides indirect
pressure on the pelvic organs that exceeds venous and
capillary filling pressure. This stops bleeding from these
sources. Circumferential pressure also decreases actual
arterial flow. This directly decreases arterial bleeding and
hence should give normal hemostatic mechanisms more
opportunity to act. It is unfortunate that the term “anti-
shock” became incorporated into the names of these
devices because they have essentially no utility in reversing
shock in general or in preventing it from injuries that are
above the pelvis. However, emergency care and childbirth
providers need a means of slowing or stopping pelvic
hemorrhage. This is particularly true in low resource
environments or when patients present late or to facilities
that lack interventional radiology, immediate surgical
capability, and safe blood. Delays in gaining access to
definitive care are even more serious if patients suffer from
preexisting anemia or have little reserve.
Although we did not do any formal testing of device
acceptability, we did ask all of the subjects if they
wanted the trial terminated because the devices were too
uncomfortable and none did. One subject had participat-
ed in a previous PASG study and spontaneously
volunteered that all three devices felt “about the same”
which is reassuring given the long clinical experience
with commercial PASG.
Limitations of our study include the use of nonpreg-
nant subjects. The postpartum uterus is larger and has
greater blood flow than the nonpregnant uterus. How
shock affects perfusion of the postpartum uterus is not
known. In addition our subjects were euvolemic and not
bleeding. Hypovolemia ordinarily causes peripheral va-
soconstriction which would lead to less blood flow at the
distal aorta. However, sepsis and late shock cause
vasodilatation which causes opposite changes. It would
be unethical and impractical to perform an initial trial on
ill and bleeding subjects. Our within-subject experimen-
tal design specifically compensates for differing amounts
of pelvic blood flow between subjects. It should also
compensate for the above physiologic states. Although
the amount of blood flow in the distal aorta might be
different, the effect of mechanical pressure and hence the
comparison between devices would be the same. Al-
though the improvised device can be made locally, the
NASG is available in a manufactured version which may
make it more suitable in places that can afford the initial
investment. The PASG decreased blood flow by a larger
margin than the NASG, but this does not prove that it is
clinically either equivalent or superior. It should be noted
that the optimal pressure to treat pelvic and postpartum
bleeding is not known but that the pressure in each
device can be changed by adding or removing air from
the tubes or adjusting the tension on the straps of the
NASG. Currently available reports of NASG use in
obstetric hemorrhage have not noted problems with
compartment syndrome, but the number of subjects
studied is small. Randomized controlled clinical trials
of both devices are needed.
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